Patrick Trojer

Patrick Trojer, PhD, is the Chief Executive Officer and President of TRIANA Biomedicines, a biotechnology company focused on developing a molecular glue discovery platform for challenging disease targets. With extensive experience in the biotechnology sector, Patrick has held various leadership roles, including Chair of the Board of Directors at Booster Therapeutics, a position on the Scientific Advisory Board at Fulcrum Therapeutics, and advisor roles at RA Capital Management, L.P. and BiOrigin. Previously, Patrick served as Chief Scientific Officer at Constellation Pharmaceuticals, where a progressive career spanned multiple positions including Senior Vice President of Translational Research and Vice President of Research. Academic credentials include a Ph.D. in Biochemistry and Molecular Biology and an MS in Microbiology and Biochemistry, both from Universität Innsbruck.